Organon and Roche settle patent dispute:
This article was originally published in Clinica
Executive Summary
Organon Teknika has settled all patent litigation relating to nucleic acid amplification technology with Swiss company Hoffmann-La Roche. As a result of the settlement, Dutch company Organon will be able to expand its NucliSens product line, which is based on NASBA RNA transcription amplification.